This article is more than 5 years old. Information may no longer be current.
Surgeons report promising early results with new combined vitrectomy and phaco platform
Click Here to Manage Email Alerts
PARIS — Two European surgeons reported positive early experience with the Stellaris PC, Bausch + Lomb's new combination vitrectomy and phacoemulsification system.
B+L hosted a press conference at the European Society Cataract and Refractive Surgeons meeting here to discuss new corporate initiatives and products including the Stellaris PC, which stands for "Procedural Choice."
"The new Stellaris PC combined surgical platform has an excellent performance that makes retinal surgery safer, less invasive, easier, and faster," said Dr. Ignasi Jürgens, MD, PhD, who reported the early clinical results and surgeon impressions of 108 surgical procedures conducted in six European countries.
Dr. Jürgens, who performed 15 of the 108 cases, said all of his patients 1 month postop had significantly improved BCVA.
Surgeons with early clinical experience were asked their impression of the machine's performance and all reported it was "excellent," Dr. Jürgens said.
Also, 90% of surgeons reported that they would recommend or highly recommend the Stellaris PC to a colleague.
"Stellaris was already the best machine in cataract surgery," said Roberto Belluci, MD. But surgeons needed a machine that had the advantages of MICS combined with sutureless 23G and 25G vitrectomy features, he said.
Dr. Bellucci said that the Stellaris PC performs at 5,000 cpm, which gives "low traction and high safety"; has a new handpiece that is more rigid; a shorter distance to the mouth and the system that reports to the surgeon where the mouth is; yellow, green and amber color filters; and two illumination sources. The Stellaris PC eliminates the need to change the tubing in a combined surgery, he said.